Cytotoxicity studies of lycorine alkaloids of the amaryllidaceae

Natural Product Communications

Volumn 9, Issue 8, 2014, Pages 1193-1210

  Nair, Jerald J ^a   Van Staden, Johannes ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

Alkaloids; Amaryllidaceae; Anticancer; Cytotoxic; Lycorine

Indexed keywords

ALKALOID DERIVATIVE; AMARYLLIDACEAE ALKALOID; ANTINEOPLASTIC AGENT; GALANTAMINE; LYCORINE; LYCORINE ALKALOID; UNCLASSIFIED DRUG;

AMARYLLIDACEAE; ANTIMALARIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; BIOLOGICAL ACTIVITY; BREAST CANCER; CHEMICAL ANALYSIS; CHEMICAL MODIFICATION; COLON CANCER; CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; ENZYME INHIBITION; HELA CELL LINE; HUMAN; IC 50; LEUKEMIA CELL LINE; LIVER CELL CARCINOMA; LYMPHATIC LEUKEMIA; LYMPHOMA; MELANOMA CELL LINE; MEMBRANE STABILIZATION; MINIMUM INHIBITORY CONCENTRATION; MYELOID LEUKEMIA; NONHUMAN; OUTCOME ASSESSMENT; REVIEW; RHABDOMYOSARCOMA; SQUAMOUS CELL CARCINOMA; STRUCTURE ACTIVITY RELATION;

AMARYLLIDACEAE ALKALOIDS; ANIMALS; HUMANS; LILIACEAE; PHENANTHRIDINES; PLANT EXTRACTS;

EID: 84906681208     PISSN: 1934578X     EISSN: 15559475     Source Type: Journal    
DOI: 10.1177/1934578x1400900834     Document Type: Review

References (97)

1. Tan GT, Gylenhaal C, Soejarto DD. (2006) Biodiversity as a source of anticancer drugs. Current Drug Targets, 7, 265-277.
2. Cragg GM, Grothaus PG, Newman DJ. (2009) Impact of natural products on developing new anti-cancer agents. Chemical Reviews, 109, 3012-3043.
3. Pan L, Chai H, Kinghorn AD. (2010) The continuing search for antitumor agents from higher plants. Phytochemistry Letters, 3, 1-8.
4. (a) Newman DJ, Cragg GM. (2007) Natural products as sources of new drugs over the last 25 years. Journal of Natural Products, 70, 461-477;
5. (b) Newman DJ, Cragg GM. (2012) Natural products as sources of new drugs over the 30 years from 1981 to 2010. Journal of Natural Products, 75, 311-335.
6. (a) Viladomat F, Bastida J, Codina C, Nair JJ, Campbell WE. (1997) Alkaloids of the South African Amaryllidaceae. In Recent Research Developments in Phytochemistry. Vol. 1, Pandali SG (Ed). Research Signpost Publishers, Trivandrum, India, 131-171;
7. (b) Nair JJ, Bastida J, Codina C, Viladomat F, Van Staden J. (2013) Alkaloids of the South African Amaryllidaceae: a review. Natural Product Communications, 8, 1335-1550;
8. (c) Bastida J, Lavilla R, Viladomat F. (2006) Chemical and biological aspects of Narcissus alkaloids. In The Alkaloids. Cordell GA (Ed). Elsevier, Amsterdam, Netherlands, 87-179;
9. (d) Jin Z. (2013) Amaryllidaceae and Sceletium alkaloids. Natural Product Reports, 30, 849-868.
10. (a) Caamal-Fuentes E, Torres-Tapia LW, Simá-Polanco P, Peraza-Sánchez SR, Moo-Puc R. (2011) Screening of plants used in Mayan traditional medicine to treat cancer-like symptoms. Journal of Ethnopharmacology, 135, 719-724;
11. (b) Kornienko A, Evidente A. (2008) Chemistry, biology and medicinal potential of narciclasine and its congeners. Chemical Reviews, 108, 1982-2014;
12. (c) Nair JJ, Van Staden J. (2013) Pharmacological and toxicological insights to the South African Amaryllidaceae. Food and Chemical Toxicology, 62, 262-275.
13. (a) Heinrich M, Teoh HL. (2004) Galanthamine from snowdrop- the development of a modern drug against Alzheimer's disease from local Caucasian knowledge. Journal of Ethnopharmacology, 92, 147-162;
14. (b) Williams P, Sorribas A, Howes M-J. (2011) Natural drugs as a source of Alzheimer's drug leads. Natural Product Reports, 28, 48-77.
15. (a) Bastida J, Berkov S, Torras L, Pigni NB, De Andrade JP, Martinez V, Codina C, Viladomat F. (2011) Chemical and biological aspects of Amaryllidaceae alkaloids. In Recent Advances in Pharmaceutical Sciences. Muòoz-Torrero D (Ed). Transworld Research Network, Trivandrum, India, 65-100;
16. (b) Nair JJ, Bastida J, Viladomat F, Van Staden J. (2012) Cytotoxic agents of the crinane series of Amaryllidaceae alkaloids. Natural Product Communications, 7, 1677-1688.
17. Cao Z, Yang P, Zhou Q. (2013) Multiple biological functions and pharmacological effects of lycorine. Science China Chemistry, 56, 1382-1391.
18. (a) Ingrassia L, Lefranc F, Mathieu V, Darro F, Kiss R. (2008) Amaryllidaceae isocarbostyril alkaloids and their derivatives as promising antitumor agents. Translational Oncology, 1, 1-13;
19. (b) Evidente A, Kornienko A. (2009) Anticancer evaluation of structurally diverse Amaryllidaceae alkaloids and their synthetic derivatives. Phytochemistry Reviews, 8, 449-459;
20. (c) Evidente A, Kireev AS, Jenkins AR, Romero AE, Steelant WFA, Van Slambrouck S, Kornienko A. (2009) Biological evaluation of structurally diverse Amaryllidaceae alkaloids and their synthetic derivatives: discovery of novel leads for anticancer drug design. Planta Medica, 75, 501-507;
21. (d) Lamoral-Theys D, Decaestecker C, Mathieu V, Dubois J, Kornienko A, Kiss R, Evidente A, Pottier L. (2010) Lycorine and its derivatives for anticancer drug design. Mini-Reviews in Medicinal Chemistry, 10, 41-50.
22. (a) Yamaguchi K, Suda S. (1952) The changes in spermatocytes of Vicia faba treated with lycorine or lycorenine. Folia Pharmacologica Japonica, 48, 31-32;
23. (b) De Leo P, Dalessandro G, De Santis A, Arrigoni O. (1973) Inhibitory effect of lycorine on cell division and cell elongation. Plant and Cell Physiology, 14, 481-486;
24. (c) De Leo P, Dalessandro G, De Santis A, Arrigoni O. (1973) Metabolic responses to lycorine in plants. Plant and Cell Physiology, 14, 487-496;
25. (d) Jimenez A, Sanchez L, Vazquez D. (1975) Yeast ribosomal sensitivity and resistance to the Amaryllidaceae alkaloids. FEBS Letters, 60, 66-70.
26. Ceriotti G. (1967) Narciclasine: an antimitotic substance from Narcisssus bulbs. Nature, 213, 595-596.
27. Furusawa E, Furusawa S, Morimoto S, Cutting W. (1971) Therapeutic activity of Narcissus alkaloid on Rauscher leukemia and comparison with standard drugs. Proceedings of the Society for Experimental Biology and Medicine, 136, 1168-1173.
28. Jimenez A, Santos A, Alonso G, Vazquez D. (1976) Inhibitors of protein synthesis in eukaryotic cells. Comparative effects of some Amaryllidaceae alkaloids. Biochimica et Biophysica Acta, 425, 342-348.
29. Zee-Cheng RK-Y, Yan S-J, Cheng CC. (1978) Antileukemic activity of ungeremine and related compounds. Preparation of analogues of ungeremine by a practical photochemical reaction. Journal of Medicinal Chemistry, 21, 199-203.
30. Furusawa E, Irie H, Combs D, Wildman WC. (1980) Therapeutic activity of pretazettine on Rauscher leukemia: comparison with the related Amaryllidaceae alkaloids. Experimental Chemotherapy, 26, 36-45. (Pubitemid 10213052)
31. Pettit GR, Gaddamidi V, Goswami A, Cragg GM. (1984) Antineoplastic agents. 99. Amaryllis belladonna. Journal of Natural Products, 47, 796-801.
32. Ghosal S, Saini KS, Razdan S. (1985a) Crinum alkaloids: their chemistry and biology. Phytochemistry, 24, 2141-2156.
33. Ghosal S, Shanthy A, Kumar A, Kumar Y. (1985b) Palmilycorine and lycoriside: acyloxy and acylglucosyloxy alkaloids from Crinum asiaticum. Phytochemistry, 24, 2703-2706.
34. Ghosal S, Kumar Y, Singh SK, Kumar A. (1986) Chemical constituents of Amaryllidaceae. Part 21. Ungeremine and criasbetaine, two antitumor alkaloids from Crinum asiaticum. Journal of Chemical Research (S), 112-113.
35. Ghosal S, Singh SK, Kumar Y, Unnikrishnan S, Chattopadhyay S. (1988) The role of ungeremine in the growth-inhibiting and cytotoxic effects of lycorine: evidence and speculation. Planta Medica, 114-116.
36. Abd El Hafiz MA, Ramadan MA, Jung ML, Beck JP, Anton R. (1991) Cytotoxic activity of Amaryllidaceae alkaloids from Crinum augustum and Crinum bulbispermum. Planta Medica, 57, 437-439.
37. Likhitwitayawuid K, Angerhofer CK, Chai H, Pezzuto JM, Cordell GA, Ruangrungsi N. (1993) Cytotoxic and antimalarial alkaloids from the bulbs of Crinum amabile. Journal of Natural Products, 56, 1331-1338. (Pubitemid 23267981)
38. Lin L-Z, Hu S-F, Chai H-B, Pengsuparp T, Pezzuto JM, Cordell GA, Ruangrungsi N. (1995) Lycorine alkaloids from Hymenocallis littoralis. Phytochemistry, 40, 1295-1298.
39. Weniger B, Italiano L, Beck JP, Bastida J, Bergoñon S, Codina C, Lobstein A, Anton R. (1995) Cytotoxic activity of Amaryllidaceae alkaloids. Planta Medica, 61, 77-79.
40. Duy HH, Shankar S, Takemoto DJ. (1997) Anticancer activities of 2,5,8,9-substituted 6-oxo-1,2,3,4,5,6-hexahydrophenanthridines on multi-drug-resistant phenotype cells. Anticancer Reserach, 17, 2435-2442.
41. Campbell WE, Nair JJ, Gammon DW, Bastida J, Codina C, Viladomat F, Smith PJ, Albrecht CF. (1998) Cytotoxic and antimalarial alkaloids from Brunsvigia littoralis. Planta Medica, 64, 91-93. (Pubitemid 28060013)
42. Nair JJ, Campbell WE, Gammon DW, Albrecht CF, Viladomat F, Codina C, Bastida J. (1998) Alkaloids from Crinum delagoense. Phytochemistry, 49, 2539-2543.
43. Campbell WE, Nair JJ, Gammon DW, Codina C, Bastida J, Viladomat F, Smith PJ, Albrecht CF. (2000) Bioactive alkaloids from Brunsvigia radulosa. Phytochemistry, 53, 587-591. (Pubitemid 30136771)
44. Stark LM, Lin X-F, Flippin LA. (2000) Total synthesis of Amaryllidaceae pyrrolophenanthridinium alkaloids via the Ziegler-Ullmann reaction: Tortuosine, criasbetaine and ungeremine. Journal of Organic Chemistry, 65, 3227-3230. (Pubitemid 30329191)
45. Barthelmes HU, Niederberger E, Roth T, Schulte K, Tang WC, Boege F, Fiebig H-H, Eisenbrand G, Marko D. (2001) Lycobetaine as a selective topoisomerase IIβ poison and inhibits the growth of human tumour cells. British Journal of Cancer, 85, 1585-1591. (Pubitemid 34001594)
46. Min BS, Gao JJ, Nakamura N, Kim YH, Hattori M. (2001) Cytotoxic alkaloids and a flavan from the bulbs of Crinum asiaticum var. japonicum . Chemical and Pharmaceutical Bulletin, 49, 1217-1219. (Pubitemid 32847539)
47. Hohmann J, Forgo P, Molnár J, Wolfard K, Molnár A, Thalhammer T, Mathé I, Sharples D. (2002) Antiproliferative Amaryllidaceae alkaloids isolated from the bulbs of Sprekelia formosissima and Hymenocallis x festalis. Planta Medica, 68, 454-457. (Pubitemid 34606692)
48. Phan TS, Tran BD, Bach D, Phan MG, Nguyen TM, Hoang TH, Le MH. (2003) Investigation of antimicrobial and cytotoxic properties of alkaloids from some species of Crinum in Vietnam. Tap Chi Duoc Hoc, 4, 18-21.
49. Liu J, Hu W, He L, Ye M, Li Y. (2004) Effects of lycorine on HL-60 cells via arresting cell cycle and inducing apoptosis. FEBS letters, 578, 245-250. (Pubitemid 39601789)
50. Liu J, Li Y, Tang LJ, Zhang GP, Hu WX. (2007) Treatment of lycorine on SCID mice model with human APL cells. Biomedicine & Pharmacotherapy, 61, 229-234. (Pubitemid 46686980)
51. Li S, Chen C, Zhang H, Guo H, Wang H, Wang L, Zhang X, Hua S, Yu J, Xiao P, Li Y, Liu J, Tang L, Shi Y, Ren W, Hu W. (2007) Apoptosis induced by lycorine in KM3 cells is associated with the G0/G1 cell cycle arrest. Oncology Reports, 17, 377-384.
52. Berkov S, Reyes-Chilipa R, Codina C, Viladomat F, Bastida J. (2007) Revised NMR data for incartine: an alkaloid from Galanthus elwesii. Molecules, 12, 1430-1435.
53. Toriizuka Y, Kinoshita E, Kogure N, Kitajima M, Ishiyama A, Otoguro K, Yamada H, Ōmura S, Takayama H. (2008) New lycorine-type alkaloid from Lycoris traubii and evaluation of antitrypanosomal and antimalarial activities of lycorine derivatives. Bioorganic & Medicinal Chemistry, 16, 10182-10189. (Pubitemid 50331576)
54. Liu X-S, Jiang J, Jiao X-Y, Wu Y-E, Lin J-H, Cai Y-M. (2009) Lycorine induces apoptosis and down-regulation of Mcl-1 in human leukemia cells. Cancer Letters, 274, 16-24.
55. Zupkó I, Réthey B, Hohmann J, Molnár J, Ocsovski I, Falkay G. (2009) Antitumor activity of alkaloids derived from Amaryllidaceae species. In Vivo, 23, 41-48.
56. Sun Q, Shen Y-H, Tian J-M, Tang J, Su J, Liu R-H, Li H-L, Xu X-K, Zhang W-D. (2009) Chemical constituents of Crinum asiaticum L. var. sinicum Baker and their cytotoxic activities. Chemistry & Biodiversity, 6, 1751-1757.
57. Zhou G, Puig-Basagoiti F, Zhang B, Qing M, Chen L, Pankiewicz KW, Felczak K, Yuan Z, Shi P-Y. (2009) A single-amino acid substitution in West Nile virus 2K peptide between NS4A and NS4B confers resistance to lycorine, a flavivirus inhibitor. Virology, 384, 242-252.
58. McNulty J, Nair JJ, Bastida J, Pandey S, Griffin C. (2009) Structure-activity studies on the lycorine pharmacophore: a potent inducer of apoptosis in human leukemia cells. Phytochemistry, 70, 913-919.
59. Jitsuno M, Yokosuka A, Sakagami H, Mimaki Y. (2009) Chemical constituents of the bulbs of Habranthus brachyandrus and their cytotoxic activities. Chemical and Pharmaceutical Bulletin, 57, 1153-1157.
60. Lamoral-Theys D, Andolfi A, Van Goietsenoven G, Cimmino A, Le Calvé B, Wauthoz N, Mégalizzi V, Gras T, Bruyère C, Dubois J, Mathieu V, Kornienko A, Kiss R, Evidente A. (2009) Lycorine, the main phenanthridine Amaryllidaceae alkaloid, exhibits significant antitumor activity in cancer cells that display resistance to proapoptotic stimuli: an investigation of structure-activity relationship and mechanistic insight. Journal of Medicinal Chemistry, 52, 6244-6256.
61. www.http://pubchem.ncbi.nlm.nih.gov/search/search.cgi (structure search).
62. Van Goietsenoven G, Andolfi A, Lallemand B, Cimmino A, Lamoral-Theys D, Gras T, Abou-Donia A, Dubois J, Lefranc F, Mathieu V, Kornienko A, Kiss R, Evidente A. (2010) Amaryllidaceae alkaloids belonging to different structural subgroups display activity against apoptosis-resistant cancer cells. Journal of Natural Products, 73, 1223-1227.
63. Osorio EJ, Berkov S, Brun R, Codina C, Viladomat F, Cabezas F, Bastida J. (2010) In vitro antiprotozoal activity of alkaloids from Phaedranassa dubia (Amaryllidaceae). Phytochemistry Letters, 3, 161-163.
64. Van Goietsenoven G, Hutton J, Becker J-P, Lallemand B, Robert F, Lefranc F, Pirker C, Vandenbussche G, Van Antwerpen P, Evidente A, Berger W, Prévost M, Pelletier J, Kiss R, Kinzy TG, Kornienko A, Mathieu V. (2010) Targeting of eEF1A with Amaryllidaceae isocarbostyrils as a strategy to combat melanomas. The FASEB Journal, 24, 4575-4584.
65. Feng T, Wang Y-Y, Su J, Li Y, Cai X-H, Luo X-D. (2011) Amaryllidaceae alkaloids from Lycoris radiata. Helvetica Chimica Acta, 94, 178-183.
66. Jitsuno M, Yokosuka A, Hashimoto K, Amano O, Sakagami H, Mimaki Y. (2011) Chemical constituents of Lycoris albiflora and their cytotoxic activities. Natural Product Communications, 6, 187-192.
67. Kaya GI, Sarikaya B, Onur MA, Somer NU, Viladomat F, Codina C, Bastida B, Lauinger IL, Kaiser M, Tasdemir D. (2011) Antiprotozoal alkaloids from Galanthus trojanus. Phytochemistry Letters, 4, 301-305.
68. Liu J, Yang Y, Xu Y, Ma C, Qin C, Zhang L. (2011) Lycorine reduces mortality of human enterovirus 71-infected mice by inhibiting virus replication. Virology Journal, 8, 483-491.
69. Evdokimov NM, Lamoral-Theys D, Mathieu V, Andolfi A, Frolova LV, Pelly SC, Van Otterlo WAL, Magedov IV, Kiss R, Evidente A, Kornienko A. (2011) In search of a cytostatic agent derived from the alkaloid lycorine: synthesis and growth inhibitory properties of lycorine derivatives. Bioorganic & Medicinal Chemistry, 19, 7252-7261.
70. Kang J, Zhang Y, Cao X, Fan J, Li G, Wang Q, Diao Y, Zhao Z, Luo L, Yin Z. (2012) Lycorine inhibits lipopolysaccharide-induced iNOS and COX-2 up-regulation in RAW264.7 cells through suppressing P38 and STATs activation and increases the survival rate of mice after LPS challenge. International Immunopharmacology, 12, 249-256.
71. Luo Z, Wang F, Zhang J, Li X, Zhang M, Hao X, Xue Y, Li Y, Horgen FD, Yao G, Zhang Y. (2012) Cytotoxic alkaloids from the whole plants of Zephyranthes candida. Journal of Natural Products, 75, 2113-2120.
72. Li L, Dai H-J, Ye M, Wang S-L, Xiao X-J, Zheng J, Chen H-Y, Luo Y-H, Liu J. (2012) Lycorine induces cell-cycle arrest in the G0/G1 phase in K562 cells via HDAC inhibition. Cancer Cell International, 12, 49-54.
73. He J, Qi W-B, Tian J, Jiao P-R, Liu G-Q, Zhang C-H, Liao M. (2012) Amaryllidaceae alkaloids exhibit anti-influenza activity in MDCK cells, an investigation of Amaryllidaceae alkaloids and MDCK cells insight. Journal of Animal and Veterinary Advances, 11, 2485-2492.
74. Nair JJ, Rárová L, Strnad M, Bastida J, Van Staden J. (2012) Apoptosis-inducing effects of distichamine and narciprimine, rare alkaloids of the plant family Amaryllidaceae. Bioorganic & Medicinal Chemistry Letters, 22, 6195-6199.
75. waf1/cip1 identifies HIF prolyl hydroxylase inhibitors as neuroprotective agents with antitumor properties. Neurobiology of Disease, 49, 13-21.
76. Katoch D, Kumar D, Sharma U, Kumar N, Padwad YS, Lal B, Singh B. (2013) Zephgrabetaine: a new betaine-type Amaryllidaceae alkaloid from Zephyranthes grandiflora. Natural Product Communications, 8, 161-164.
77. Cao Z, Yu D, Fu S, Zhang G, Pan Y, Bao M, Tu J, Shang B, Guo P, Yang P, Zhou Q. (2013) Lycorine hydrochloride selectively inhibits human ovarian cancer cell proliferation and tumor neovascularization with very low toxicity. Toxicology Letters, 218, 174-185.
78. Hao B, Shen S-F, Zhao Q-J. (2013) Cytotoxic and antimalarial alkaloids from the bulbs of Lycoris radiata. Molecules, 18, 2458-2468.
79. Cao P, Pan D-S, Han S, Yu C-Y, Zhao Q-J, Song Y, Liang Y. (2013) Alkaloids from Lycoris caldwelli and their particular cytotoxicities against the astrocytoma and glioma cell lines. Archives of Pharmacal Research, 36, 927-932.
80. Nair JJ, Rárová L, Strnad M, Bastida J, Van Staden J. (2013) Alkaloids from Boophone haemanthoides (Amaryllidaceae). Natural Product Communications, 8, 1705-1710.
81. Dasari R, Banuls LMY, Masi M, Pelly SC, Mathieu V, Green IR, Van Otterlo WAL, Evidente A, Kiss R, Kornienko A. (2014) C1,C2-ether derivatives of the Amaryllidaceae alkaloid lycorine: retention of activity of highly lipophilic analogues against cancer cells. Bioorganic & Medicinal Chemistry, 24, 923-927.
82. Wang P, Yuan H-H, Zhang X, Li Y-P, Shang L-Q, Yin Z. (2014) Novel lycorine derivatives as anticancer agents: synthesis and in vitro biological evaluation. Molecules, 19, 2469-2480.
83. Karadeniz H, Gulmez B, Sahinci F, Erdem A, Kaya GI, Unver N, Kivcak B, Ozsoz M. (2003) Disposable electrochemical biosensor for the detection of the interaction between DNA and lycorine based on guanine and adenine signals. Journal of Pharmaceutical and Biomedical Analysis, 33, 295-302. (Pubitemid 37101446)
84. Vrijsen R, Vanden Berghe DA, Vlietinck AJ, Boeyé A. (1986) Lycorine: a eukaryotic termination inhibitor. The Journal of Biological Chemistry, 261, 505-507.
85. Kukhanova M, Victorova L, Krayevsky A. (1983) Peptidyltransferase center of ribosomes. On the mechanism of action of alkaloid lycorine. FEBS letters, 160, 129-133. (Pubitemid 13048731)
86. Papas TS, Sandhaus L, Chirigos MA, Furusawa E. (1973) Inhibition of DNA polymerase of avian myeloblastosis virus by an alkaloid extract from Narcissus tazetta L. Biochemical and Biophysical Research Communications, 52, 88-92.
87. Arrigoni O, Arrigoni LR, Calabrese G. (1975) Lycorine as an inhibitor of ascorbic acid biosynthesis. Nature, 256, 513-514.
88. Liu R, Cao Z, Tu J, Pan Y, Shang B, Zhang G, Bao M, Zhang S, Yang P, Zhou Q. (2012) Lycorine hydrochloride inhibits metastatic melanoma cell-dominant vasculogenic mimicry. Pigment Cell & Melanoma Research, 25, 630-638.
89. Xu W, Liu LZ, Loizidou M, Ahmed M, Charles IG. (2002) The role of nitric oxide in cancer. Cell Research, 12, 311-320. (Pubitemid 135708343)
90. Abdel-Halim OB, Morikawa T, Ando S, Matsuda H, Yoshikawa M. (2004) New crinine-type alkaloids with inhibitory effect on induction of inducible nitric oxide synthase from Crinum yemense. Journal of Natural Products, 67, 1119-1124. (Pubitemid 38971671)
91. Paul AT, Gohil VM, Bhutani KK. (2006) Modulating TNF-α signaling with natural products. Drug Discovery Today, 11, 725-732. (Pubitemid 44038620)
92. Liu J, Hu J-L, Shi B-W, He Y, Hu W-X. (2010) Up-regulation of p21 and TNF-α is mediated in lycorine-induced death of HL-60 cells. Cancer Cell International, 10, 25-33.
93. Ancuceanu RV, Istudor V. (2004) Pharmacologically active natural compounds for lung cancer. Alternative Medicine Review, 9, 402-419. (Pubitemid 40066714)
94. Casu L, Cottiglia F, Leonti M, De Logu A, Agus E, Tse-Dinh Y-C, Lombardo V, Sissi C. (2011) Ungeremine effectively targets mammalian as well as bacterial type I and type II topoisomerases. Bioorganic & Medicinal Chemistry Letters, 21, 7041-7044.
95. Yui S, Mikami M, Kitahara M, Yamazaki M. (1998) The inhibitory effect of lycorine on tumor cell apoptosis induced by polymorphonuclear leukocyte-derived calprotectin. Immunopharmacology, 40, 151-162. (Pubitemid 28439169)
96. Mikami M, Kitahara M, Kitano M, Ariki Y, Mimaki Y, Sashida Y, Yamazaki M, Yui S. (1999) Suppressive activity of lycoricidinol (narciclasine) against cytotoxicity of neutrophil-derived calprotectin, and its suppressive effect on rat adjuvant arthritis model. Biological and Pharmaceutical Bulletin, 22, 674-678. (Pubitemid 29361697)
97. Yui S, Nakatani Y, Mikami M. (2003) Calprotectin (S100A8/S100A9), an inflammatory protein complex from neutrophils with a broad apoptosis-inducing activity. Biological and Pharmaceutical Bulletin, 26, 753-760. (Pubitemid 39655290)